A Phase IV, Randomized, Open-label, Comparative, Single-center Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf (Modified Release Tacrolimus) and Prograf (Tacrolimus) in de Novo Living Donor Liver Transplant Recipients
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus
- Indications Liver transplant rejection
- Focus Pharmacokinetics
- Acronyms MAIN
- Sponsors Astellas Pharma
- 27 Oct 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 17 Oct 2012 Planned End Date changed from 1 Sep 2012 to 1 Aug 2014 as reported by ClinicalTrials.gov.
- 26 Apr 2011 New trial record